Evidence map›Paper›PMID 32300427›Full record

ArticleJournal of hematology2018

Irline Cordeiro de Macedo Pontes, Marjory Medeiro Passos Teixeira, Naisa Bezerra de Carvalho, Milton da Silva Linhares Junior, Luis Fabio Barbosa Botelho

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Irline Cordeiro de Macedo PontesUniversidade Federal da Paraiba (UFPB), Hospital Universitario Lauro Wanderley (HULW), Joao Pessoa-PB, Brazil.
Marjory Medeiro Passos TeixeiraUniversidade Federal da Paraiba (UFPB), Hospital Universitario Lauro Wanderley (HULW), Joao Pessoa-PB, Brazil.
Naisa Bezerra de CarvalhoUniversidade Federal da Paraiba (UFPB), Hospital Universitario Lauro Wanderley (HULW), Joao Pessoa-PB, Brazil.
Milton da Silva Linhares JuniorUniversidade Federal da Paraiba (UFPB), Hospital Universitario Lauro Wanderley (HULW), Joao Pessoa-PB, Brazil.
Luis Fabio Barbosa BotelhoHematology Unit, Department of Internal Medicine, Universidade Federal da Paraiba (UFPB), Hospital Universitario Lauro Wanderley (HULW), Joao Pessoa-PB, Brazil.
Hospital Universitário Lauro Wanderley · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lymphoid leukemia (ALL) is a malignant proliferation of abnormal lymphoid precursors in the bone marrow. It is the most common acute leukemia in childhood, accounting for only 20% of acute leukemia in adults. The clinical presentation is heterogeneous including pallor, fatigue and weakness. Diagnosis is performed through myelogram, bone marrow biopsy and immunophenotyping. Chemotherapy and, in some cases, bone marrow transplantation (BMT) are used to treat the disease. However, the efficacy of treatment in adult patients is still below expected and therapeutic innovations have not increased disease-free survival. In addition, about 20% of patients have relapse, usually generalized, of the disease. This article aims to report the case of a patient previously treated for ALL B presenting localized medullar relapse or

Indexed as

Precursor cell lymphoblastic leukemia-lymphomaRecurrenceTherapeutics

Identifiers

PMID32300427
PMCPMC7155833
OpenAlexW2889074262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.